Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109097409A reveals dual-product enzymatic route. High purity D-amino acids and alpha keto acids. Cost-effective supply chain solutions for global pharmaceutical manufacturing.
Patent CN102557925A reveals a high-yield dilute nitric acid oxidation route for 2,3,3',4'-diphenyl ether tetracarboxylic acid, offering significant cost reduction in electronic chemical manufacturing.
Patent CN116848257A enables green production of (R)-mandelic acid. Achieve cost reduction in pharmaceutical intermediates manufacturing with sustainable enzyme cascades.
Patent CN1021439C details a high-yield nickel-catalyzed coupling for 3,3',4,4'-biphenyltetracarboxylic acid, offering significant cost reduction and supply chain stability for polyimide manufacturing.
Patent CN111423296A reveals a metal-free, one-pot synthesis for beta-haloenamic acid esters. This breakthrough offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN104788483B reveals scalable synthesis for high-purity phenylboronic acids offering significant supply chain stability and cost efficiency for pharmaceutical intermediates.
Patent CN113461583B details a novel astaxanthin synthesis avoiding hazardous reagents. Discover high-yield manufacturing and cost reduction strategies.
Patent CN107074761B reveals a sustainable route to epsilon-caprolactam from biomass, eliminating ammonium sulfate waste and offering a reliable polyamide intermediate supplier solution.
Patent CN101516898B details a novel asymmetric Strecker reaction for L-AMPB production, offering significant cost reduction in herbicide manufacturing and scalable supply chain solutions.
Novel ionic liquid catalyst method for aromatic carboxylic acids. Reduces toxic solvents and metal waste. Reliable supply for pharma intermediates ensuring cost efficiency.
Novel asymmetric synthesis of chiral dihydrofurans via squaric acid catalysis. High enantioselectivity and mild conditions for API manufacturing.
Patent CN116143586B details a safer route for valproate impurity synthesis, offering cost reduction and scalable supply chain solutions for global manufacturers.
Patent CN1798609A reveals a novel copper catalyst system enabling high-yield, low-temperature synthesis of optically active cyclopropane compounds for pyrethroid production.
Advanced synthesis of flunixin meglumine intermediate via high-pressure fluorination. Delivers high purity and scalable manufacturing for veterinary pharmaceuticals.
Patent CN115557846A reveals a safe, chromium-free synthesis for 8-aminocaprylic acid, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN113024554A reveals a novel one-pot cyclization for Lumateperone intermediates, offering significant cost reduction and scalable manufacturing advantages for pharmaceutical supply chains.
Patent CN101177398B details a novel purification method for Triflusal, achieving >99.5% purity via alkaline dissolution and THF/cyclohexane recrystallization, ensuring supply chain stability.
Patent CN105039435A details yeast biocatalysis for high-purity chiral intermediates. Achieve significant cost reduction and supply chain reliability with scalable green manufacturing.
Patent CN1197848C reveals a novel Pt/C catalytic hydrogenation route for isoindoline, offering superior purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN104628572B reveals a cost-effective synthesis route for herbicide intermediates. This report analyzes supply chain stability and purity advantages for global procurement.